Researchers and clinicians hope to make using biomarkers to diagnose TBI in infants or even in pre-natal cord blood a reality.
See more videos with Dr. Ronald Hayes.
Posted on BrainLine April 2, 2013.
Produced by Brian King, Vicky Youcha, and Erica Queen, BrainLine.
About the author: Ronald Hayes, PhD
Ronald Hayes, PhD is a co-founder and president of Banyan Biomarkers, Inc. He is director of Banyan’s Clinical Programs and Banyan Laboratories.